Services · Fiscal year end Dec 31

baby calendar Inc.

7363

株式会社ベビーカレンダー

FIGI BBG00Q98WDK97363.T7363 JPCorp. no. 5010401065685

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-08-14

For the first half of the fiscal year to 2026-12: Revenue ¥1 billion (+4.4% YoY), Ordinary income ¥0.1 billion (-18.9% YoY), Net income ¥0 billion (-24.0% YoY).

	This period	Year on year
Revenue	¥961m	+4.4%
Ordinary profit	¥78m	-18.9%
Net profit to owners	¥45m	-24.0%

From the securities report on EDINET, which states no forecast. History via /v1/companies/7363/earnings-releases.

Financials

Japan GAAP · non-consolidated · fiscal year to 2025-12-31

Revenue: ¥1.9bn
Net income: ¥45m
ROE: 6.4%
Equity ratio: 39.8%
Dividend / share: —
Employees: 74

Revenue · ¥bn

Net income · ¥m

Fiscal year	Revenue	Net income	Total assets	Net assets	ROE	EPS	Operating CF
2025-12-31	¥1,927m	¥45m	¥1,801m	¥728m	6.4%	¥50	¥267m
2024-12-31	¥1,528m	−¥15m	¥1,527m	¥673m	—	¥-16.46	¥195m
2023-12-31	¥1,203m	−¥100m	¥1,021m	¥706m	—	¥-111.17	−¥14m
2022-12-31	¥1,085m	¥21m	¥1,130m	¥806m	2.5%	¥22.94	−¥3m
2021-12-31	¥1,043m	¥75m	¥1,358m	¥872m	12.3%	¥87.66	¥96m

Indicators

Computed by us from filings · fiscal year to 2025-12-31

Metric	Value	Percentile among listed companies
ROE, %	6.4	34.7
Ordinary margin	0.1062	70.8
Equity ratio, %	39.8	26.7
Revenue growth	0.2613	92
Net income growth	4.0575	96.9
Operating cash flow / assets	0.1484	89.4

Policy-uncertainty measure0.00 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.

Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 2.0% held by other listed companies.

Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥617m of reported debt repriced by 50 basis points, a year's interest would rise by ¥3m, 1.1% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/7363/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them

Internal control, 2026-06-30: see filing したがって、基準日現在において、当社の財務報告に係る内部統制は有効ではないと判断しました。 Filing

Auditor change, 2026-04-23: see filing Filing

Segments, votes and tender offers

Stated in EDINET filings

Segments: Media Business for Pregnancy Childbirth and Childcare, Developing Management Support Solution Business for Obstetrics and Gynecology. /v1/companies/7363/segments

5% filings

Large shareholding reports on 7363

Filed	Filer	Stake	Change	Stated purpose
2021-11-25	Takatani Consulting Inc.	9.06%	0.00pt	pure investment

Cross-shareholdings

From the annual report's status of shareholdings

Listed strategic holdings: — issues
Book value: —
Sold in the year: — — issues
Bought in the year: — — issues
Mutual, both reports: 0
Held by listed cos.: 1

Held by: StemCell Institute Inc. 7096

Purposes, all holdings and mutual flags via /v1/companies/7363/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31

Shareholder	Shares	Ratio
individual holder	201,500	22.62%
individual holder	188,500	21.16%
株式会社SBI証券	31,100	3.49%
ASGJapan株式会社	28,100	3.15%
楽天証券株式会社	24,100	2.71%
individual holder	21,500	2.41%
株式会社ステムセル研究所	18,800	2.11%
オオサキメディカル株式会社	15,000	1.68%
大津紡績株式会社	15,000	1.68%
individual holder	11,968	1.34%

Get this as JSON

GET /v1/companies/7363
GET /v1/companies/7363/financials
GET /v1/companies/7363/details
GET /v1/companies/7363/segments
GET /v1/companies/7363/voting
GET /v1/companies/7363/tender-offers
GET /v1/companies/7363/indicators
GET /v1/companies/7363/earnings-releases
GET /v1/events?ticker=7363
GET /v1/companies/7363/trades         
GET /v1/companies/7363/cross-holdings 
GET /v1/companies/7363/brief

Plans from $9 a month · Documentation